Aigen Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,335
| Closed | -$298K | – | 778 |
|
|
2024
Q3 | $298K | Buy |
+6,335
| New | +$298K | 0.06% | 474 |
|
|
2024
Q2 | – | Sell |
-6,656
| Closed | -$454K | – | 825 |
|
|
2024
Q1 | $454K | Buy |
+6,656
| New | +$454K | 0.1% | 305 |
|
|
2022
Q1 | – | Sell |
-6,916
| Closed | -$488K | – | 651 |
|
|
2021
Q4 | $488K | Buy |
6,916
+4,044
| +141% | +$285K | 0.03% | 631 |
|
|
2021
Q3 | $321K | Sell |
2,872
-34,204
| -92% | -$3.82M | 0.06% | 328 |
|
|
2021
Q2 | $6M | Sell |
37,076
-16,859
| -31% | -$2.73M | 1.05% | 18 |
|
|
2021
Q1 | $6.57M | Buy |
53,935
+33,737
| +167% | +$4.11M | 0.87% | 19 |
|
|
2020
Q4 | $3.09M | Buy |
+20,198
| New | +$3.09M | 0.4% | 51 |
|